Skip to main content
Clinical Trials/NCT03293979
NCT03293979CompletedNot Applicable

Alere i FluA*B Biologic Test Relocated in Emergency Service for Flu Diagnosis

Fondation Hôpital Saint-Joseph1 site in 1 country301 target enrollmentStarted: January 22, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
301
Locations
1
Primary Endpoint
time to have the result of the biological test

Study Overview

Brief Summary

It appears that the heavyness of flu pathology, the diagnosis limits and the validity of it was well studied in the last years.However, the economical impact and the organisation benefit in emergency service is not yet evaluated Our purpose is to study the impact of implementation of fast flu diagnosis by molecular biology available in emergency service in the economic field .

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • respiratory symptoms
  • fever >38°C
  • general symptoms of flu like pathology

Exclusion Criteria

  • cognitive disorders
  • patient with guardianship
  • patient already having a flu diagnosis in the last 7 days
  • without social protection.

Outcomes

Primary Outcomes

time to have the result of the biological test

Time Frame: 3 hours

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Alere i FluA*B Biologic Test Relocated in... | Clinical Trial